Masashi Tanaka Selected Research

Masashi Tanaka Research Topics

Disease

21	Neoplasms (Cancer) 02/2022 - 01/2002
20	Mitochondrial Diseases (Mitochondrial Disease) 10/2020 - 01/2002
10	Myocardial Infarction 05/2020 - 12/2002
10	Hypertension (High Blood Pressure) 06/2017 - 01/2002
9	Alzheimer Disease (Alzheimer's Disease) 07/2021 - 01/2005
8	Type 2 Diabetes Mellitus (MODY) 01/2022 - 04/2004
8	Coronary Artery Disease (Coronary Atherosclerosis) 05/2017 - 09/2004
7	Obesity 01/2022 - 10/2003
7	Parkinson Disease (Parkinson's Disease) 06/2008 - 09/2002
6	MELAS Syndrome (Syndrome, MELAS) 01/2019 - 08/2005
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2015 - 02/2007
5	Atrial Fibrillation 06/2021 - 11/2015
5	Inflammation (Inflammations) 10/2020 - 12/2004
5	Hyperuricemia 08/2020 - 05/2003
5	Osteosarcoma (Osteogenic Sarcoma) 01/2013 - 02/2007
5	Hypercholesterolemia 06/2008 - 05/2003
4	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2021 - 01/2019
4	Insulin Resistance 10/2020 - 11/2015
4	Chronic Renal Insufficiency 08/2020 - 03/2009
4	Osteoporosis 08/2020 - 07/2010
4	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2019 - 12/2004
4	Aortic Dissection 01/2019 - 09/2003
4	Hypertriglyceridemia 01/2019 - 11/2007
4	Rupture 01/2018 - 10/2008
4	Leigh Disease (Leigh's Disease) 05/2014 - 01/2002
4	Cerebral Infarction 07/2010 - 02/2007
4	Ischemia 11/2008 - 09/2004
4	Diabetes Mellitus 06/2008 - 05/2003
4	Reperfusion Injury 05/2005 - 09/2004
3	Cognitive Dysfunction 01/2022 - 01/2019
3	Stroke (Strokes) 06/2021 - 04/2009
3	Dementia (Dementias) 03/2020 - 01/2019
3	Infections 01/2020 - 03/2002
3	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 06/2003
3	Hearing Loss (Hearing Impairment) 12/2012 - 03/2010
3	Cardiomyopathies (Cardiomyopathy) 03/2010 - 02/2007
3	Atherosclerosis 02/2007 - 09/2002
2	Shock 03/2022 - 11/2008
2	Pulmonary Embolism 01/2022 - 06/2010
2	Stomach Neoplasms (Stomach Cancer) 03/2021 - 02/2020
2	Cerebral Hemorrhage 01/2021 - 08/2008
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021 - 08/2008
2	Neuroblastoma 01/2021 - 11/2003
2	Muscle Weakness 10/2020 - 01/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2020 - 01/2020
2	Heart Rupture 05/2020 - 02/2017
2	Abscess 11/2019 - 02/2017
2	Body Weight (Weight, Body) 05/2019 - 10/2003
2	Carcinogenesis 05/2019 - 02/2003
2	Heart Failure 01/2019 - 08/2005
2	Endocarditis 02/2017 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 02/2003
2	Dyslipidemias (Dyslipidemia) 01/2017 - 03/2014

Drug/Important Bio-Agent (IBA)

25	Mitochondrial DNA (mtDNA)IBA 01/2013 - 08/2003
13	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 02/2007
9	Proteins (Proteins, Gene)FDA Link 02/2022 - 11/2003
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
9	Pyruvic Acid (Pyruvate)IBA 01/2019 - 12/2007
7	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2010
5	Lactic Acid (Lactate)FDA LinkGeneric 01/2019 - 03/2010
4	Peptides (Polypeptides)IBA 07/2021 - 05/2005
4	SodiumIBA 01/2019 - 03/2010
4	NucleotidesIBA 06/2017 - 12/2004
4	CytokinesIBA 05/2017 - 07/2002
4	EnzymesIBA 11/2015 - 01/2002
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013 - 02/2007
4	ButyrophilinsIBA 07/2012 - 07/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2005 - 05/2003
3	CreatinineIBA 06/2021 - 11/2008
3	taxifolinIBA 01/2021 - 01/2019
3	Growth Differentiation Factor 15IBA 10/2020 - 01/2015
3	AntigensIBA 02/2020 - 03/2008
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 08/2010
3	HDL CholesterolIBA 06/2017 - 11/2007
3	Triglycerides (Triacylglycerol)IBA 06/2017 - 10/2003
3	Amino Acids FDA Link 01/2017 - 09/2002
3	Phosphotransferases (Kinase)IBA 01/2017 - 09/2004
3	Apolipoproteins E (ApoE)IBA 03/2009 - 09/2002
3	ApolipoproteinsIBA 03/2009 - 09/2002
3	Cytochrome P-450 CYP3AIBA 08/2008 - 11/2007
3	Superoxides (Superoxide)IBA 02/2007 - 05/2005
2	Cell Surface ReceptorsIBA 01/2022 - 12/2018
2	Hemoglobins (Hemoglobin)IBA 06/2021 - 10/2017
2	CarbohydratesIBA 02/2020 - 01/2020
2	Uric Acid (Urate)IBA 01/2020 - 07/2017
2	Sodium-Glucose Transport ProteinsIBA 01/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 04/2019 - 01/2019
2	HDL LipoproteinsIBA 06/2017 - 07/2012
2	oxidized low density lipoproteinIBA 06/2017 - 03/2014
2	LDL CholesterolIBA 06/2017 - 11/2007
2	P-2 (P 2)IBA 06/2017 - 05/2017

Therapy/Procedure

12	Therapeutics 03/2022 - 03/2002
3	Percutaneous Coronary Intervention 09/2020 - 01/2020
3	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2018 - 04/2009
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 08/2009 - 11/2008
3	Heart Transplantation (Grafting, Heart) 09/2005 - 09/2004
3	Transplantation 08/2005 - 05/2005
2	Glycemic Control 01/2022 - 01/2020
2	Extracorporeal Membrane Oxygenation 05/2020 - 06/2010
2	Debridement 11/2019 - 02/2017